Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ raptor resources limited

Ann: AstraZeneca to use new ResApp software in clinical study, page-47

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 47 Last

Share
Profile

Follow
SortedItOut

195 Posts.

40

22/10/20

14:55

Post #: 48306622
Share

Originally posted by pilko3: ↑

So after the clinical trial does ResAp end up with another disease added to its quiver that it can detect accurately? So Astra does the clinical trial and uses the app for cough sounds that may identify if someone has lung cancer...how big is this? If RAP comes out of this with a proven method to detect lung cancer via the smartphone etc and it is proven beyond doubt via a clinical trial run by Astra then WOW! We didn't think of that whilst we were all thinking Covid-19 diagnosis. Despite the results from next weeks report it is more and more a waiting game...so we sleep for several years and when we wake up we will have a tiger by the tail...and a splash of cash plus the Planet is a better place!

Expand

This had me thinking too, based on the announcement it's more about detecting a cough occurring than analyzing the sound for cancer detection.

It could be part of it long term and just wasn't at a stage to be materially announced but caution says lets leave it at detecting a cough itself.

RAP Price at posting: 12.5¢ Sentiment: Hold Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

SS1

Sun Silver confirms high-grade extension theory at Maverick Springs with 79.6 g/t intercept

DXB

Dimerix begins recruiting young kidney disease patients in Mexico for Phase 3

GTR

GTI extends uranium mineralisation at Lo Hema through development drilling

CU6

Clarity progresses SECuRE trial with positive safety results

3 stocks with antimony news on Thursday

There are more pages in this discussion • 75 more messages in this thread...

First 47 Last

Add RAP (ASX) to my watchlist